Plasma LL-37 correlates with vitamin D and is reduced in human immunodeficiency virus-1 infected individuals not receiving antiretroviral therapy

Journal of Medical Microbiology

Volumn 63, Issue PART 7, 2014, Pages 997-1003

  Honda, Jennifer R ^a   Connick, Elizabeth ^b   MaWhinney, Samantha ^b   Chan, Edward D ^c   Flores, Sonia C ^a  

^a UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF COLORADO   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIFEDIOL; CALCITRIOL; CATHELICIDIN ANTIMICROBIAL PEPTIDE LL 37;

ADULT; ANTIRETROVIRAL THERAPY; ARTICLE; CD4 LYMPHOCYTE COUNT; CLINICAL ARTICLE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; MALE; PHARMACEUTICAL CARE; PRIORITY JOURNAL; VIRUS LOAD; VITAMIN BLOOD LEVEL;

ADULT; ANTI-HIV AGENTS; ANTIMICROBIAL CATIONIC PEPTIDES; CALCIFEDIOL; CALCITRIOL; CASE-CONTROL STUDIES; COHORT STUDIES; CROSS-SECTIONAL STUDIES; FEMALE; GENE EXPRESSION REGULATION, VIRAL; HIV INFECTIONS; HIV-1; HUMANS; MALE; MIDDLE AGED; ODDS RATIO;

EID: 84903185009     PISSN: 00222615     EISSN: None     Source Type: Journal    
DOI: 10.1099/jmm.0.070888-0     Document Type: Article

References (25)

1. Allavena, C., Delpierre, C., Cuzin, L., Rey, D., Viget, N., Bernard, J., Guillot, P., Duvivier, C., Billaud, E. & Raffi, F. (2012). High frequency of vitamin D deficiency in HIV-infected patients: effects of HIVrelated factors and antiretroviral drugs. J Antimicrob Chemother 67, 2222-2230.
2. Bang, U. C., Shakar, S. A., Hitz, M. F., Jespersen, M. S., Andersen, O., Nielsen, S. D. & Jensen, J. E. (2010). Deficiency of 25-hydroxyvitamin D in male HIV-positive patients: a descriptive cross-sectional study. Scand J Infect Dis 42, 306-310.
3. Belec, L., Meillet, D., Gaillard, O., Prazuck, T., Michel, E., Ngondi Ekome, J. & Pillot, J. (1995). Decreased cervicovaginal production of both IgA1 and IgA2 subclasses in women with AIDS. Clin Exp Immunol 101, 100-106.
4. Bhan, I., Camargo, C. A., Jr, Wenger, J., Ricciardi, C., Ye, J., Borregaard, N. & Thadhani, R. (2011). Circulating levels of 25-hydroxyvitamin D and human cathelicidin in healthy adults. J Allergy Clin Immunol 127, 1302-1304.
5. Campbell, G. R. & Spector, S. A. (2012a). Autophagy induction by vitamin D inhibits both Mycobacterium tuberculosis and human immunodeficiency virus type 1. Autophagy 8, 1523-1525.
6. Campbell, G. R. & Spector, S. A. (2012b). Vitamin D inhibits human immunodeficiency virus type 1 and Mycobacterium tuberculosis infection in macrophages through the induction of autophagy. PLoS Pathog 8, e1002689.
7. Crutchley, R. D., Gathe, J., Jr, Mayberry, C., Trieu, A., Abughosh, S. & Garey, K. W. (2012). Risk factors for vitamin D deficiency in HIVinfected patients in the south central United States. AIDS Res Hum Retroviruses 28, 454-459.
8. Dixon, B. M., Barker, T., McKinnon, T., Cuomo, J., Frei, B., Borregaard, N. & Gombart, A. F. (2012). Positive correlation between circulating cathelicidin antimicrobial peptide (hCAP18/LL-37) and 25-hydroxyvitamin D levels in healthy adults. BMC Res Notes 5, 575.
9. Dürr, U. H., Sudheendra, U. S. & Ramamoorthy, A. (2006). LL-37, the only human member of the cathelicidin family of antimicrobial peptides. Biochim Biophys Acta 1758, 1408-1425.
10. Fowler, M. G., Melnick, S. L. & Mathieson, B. J. (1997). Women and HIV. Epidemiology and global overview. Obstet Gynecol Clin North Am 24, 705-729.
11. Goleva, E., Searing, D. A., Jackson, L. P., Richers, B. N. & Leung, D. Y. (2012). Steroid requirements and immune associations with vitamin D are stronger in children than adults with asthma. J Allergy Clin Immunol 129, 1243-1251.
12. Gombart, A. F., Bhan, I., Borregaard, N., Tamez, H., Camargo, C. A., Jr, Koeffler, H. P. & Thadhani, R. (2009). Low plasma level of cathelicidin antimicrobial peptide (hCAP18) predicts increased infectious disease mortality in patients undergoing hemodialysis. Clin Infect Dis 48, 418-424.
13. Howell, A. L., Groveman, D. S., Wallace, P. K. & Fanger, M. W. (1997). HIV-1-infected monocytes and monocyte-derived macrophages are impaired in their ability to produce superoxide radicals. Int J Clin Lab Res 27, 111-117.
14. Jeng, L., Yamshchikov, A. V., Judd, S. E., Blumberg, H. M., Martin, G. S., Ziegler, T. R. & Tangpricha, V. (2009). Alterations in vitamin D status and anti-microbial peptide levels in patients in the intensive care unit with sepsis. J Transl Med 7, 28.
15. Levinson, P., Choi, R. Y., Cole, A. L., Hirbod, T., Rhedin, S., Payne, B., Guthrie, B. L., Bosire, R., Cole, A. M. & other authors (2012). HIV-neutralizing activity of cationic polypeptides in cervicovaginal secretions of women in HIV-serodiscordant relationships. PLoS ONE 7, e31996.
16. Mahmood, S. A. I. (2010). TB and HIV/AIDS in Bangladesh. J AIDS HIV Res 2, 66-78.
17. Redd, S. C., Rutherford, G. W., III, Sande, M. A., Lifson, A. R., Hadley, W. K., Facklam, R. R. & Spika, J. S. (1990). The role of human immunodeficiency virus infection in pneumococcal bacteremia in San Francisco residents. J Infect Dis 162, 1012-1017.
18. Segal, L. N., Methé, B. A., Nolan, A., Hoshino, Y., Rom, W. N., Dawson, R., Bateman, E. & Weiden, M. D. (2011). HIV-1 and bacterial pneumonia in the era of antiretroviral therapy. Proc Am Thorac Soc 8, 282-287.
19. Twigg, H. L., III, Spain, B. A., Soliman, D. M., Bowen, L. K., Heidler, K. M. & Wilkes, D. S. (1996). Impaired IgG production in the lungs of HIV-infected individuals. Cell Immunol 170, 127-133.
20. Van Den Bout-Van Den Beukel, C. J., Fievez, L., Michels, M., Sweep, F. C., Hermus, A. R., Bosch, M. E., Burger, D. M., Bravenboer, B., Koopmans, P. P. & Van Der Ven, A. J. (2008). Vitamin D deficiency among HIV type 1-infected individuals in The Netherlands: effects of antiretroviral therapy. AIDS Res Hum Retroviruses 24, 1375-1382.
21. Velasco, M., Castilla, V., Sanz, J., Gaspar, G., Condes, E., Barros, C., Cervero, M., Torres, R., Guijarro, C. & COMESEM Cohort (2009). Effect of simultaneous use of highly active antiretroviral therapy on survival of HIV patients with tuberculosis. J Acquir Immune Defic Syndr 50, 148-152.
22. Vescini, F., Cozzi-Lepri, A., Borderi, M., Re, M. C., Maggiolo, F., De Luca, A., Cassola, G., Vullo, V., Carosi, G. & other authors (2011). Prevalence of hypovitaminosis D and factors associated with vitamin D deficiency and morbidity among HIV-infected patients enrolled in a large Italian cohort. J Acquir Immune Defic Syndr 58, 163-172.
23. Viard, J. P., Souberbielle, J. C., Kirk, O., Reekie, J., Knysz, B., Losso, M., Gatell, J., Pedersen, C., Bogner, J. R. & other authors (2011). Vitamin D and clinical disease progression in HIV infection: results from the EuroSIDA study. AIDS 25, 1305-1315.
24. Wang, T. T., Nestel, F. P., Bourdeau, V., Nagai, Y., Wang, Q., Liao, J., Tavera-Mendoza, L., Lin, R., Hanrahan, J. W. & other authors (2004). Cutting edge: 1,25-dihydroxyvitamin D3 is a direct inducer of antimicrobial peptide gene expression. J Immunol 173, 2909-2912.
25. Yamshchikov, A. V., Kurbatova, E. V., Kumari, M., Blumberg, H. M., Ziegler, T. R., Ray, S. M. & Tangpricha, V. (2010). Vitamin D status and antimicrobial peptide cathelicidin (LL-37) concentrations in patients with active pulmonary tuberculosis. Am J Clin Nutr 92, 603-611.